Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Indo Livestock ExpoIndo Livestock Expo
Not Confirmed
Not Confirmed
02-04 July, 2025
Not Confirmed
Not Confirmed
03 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Indo Livestock ExpoIndo Livestock Expo
Industry Trade Show
Not Confirmed
02-04 July, 2025
Industry Trade Show
Not Confirmed
03 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
24 Jun 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219160
21 Jan 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216168
23 Sep 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217329
21 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218174
09 Jul 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216937
24 May 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214831
RLD : No
TE Code : AA
Dosage Form : SOLUTION; ORAL
Proprietary Name : AMINOCAPROIC ACID
Dosage Strength : 0.25GM/ML
Approval Date : 2022-11-04
Application Number : 216464
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : APREMILAST
Dosage Strength : 10MG
Approval Date : 2023-07-26
Application Number : 211878
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : APREMILAST
Dosage Strength : 20MG
Approval Date : 2023-07-26
Application Number : 211878
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : APREMILAST
Dosage Strength : 30MG
Approval Date : 2023-07-26
Application Number : 211878
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : BRIVARACETAM
Dosage Strength : 25mg
Approval Date :
Application Number : 214831
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : BRIVARACETAM
Dosage Strength : 50mg
Approval Date :
Application Number : 214831
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : BRIVARACETAM
Dosage Strength : 75mg
Approval Date :
Application Number : 214831
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : BRIVARACETAM
Dosage Strength : 100mg
Approval Date :
Application Number : 214831
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AB1
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Proprietary Name : BUPROPION HYDROCHLORIDE
Dosage Strength : 100MG
Approval Date : 2023-05-31
Application Number : 216800
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
RLD : No
TE Code : AB1
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Proprietary Name : BUPROPION HYDROCHLORIDE
Dosage Strength : 150MG
Approval Date : 2023-05-31
Application Number : 216800
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
ABOUT THIS PAGE